Walking A Tightrope Between Precision Diagnosis And Potential Risks

https://www.medicalexpo.com/medical-manufacturer/puncture-needle-3117.html

Core Angle:​ Focusing on the technical details, diagnostic value, and indispensable complication management of transthoracic needle biopsy (TTNB), emphasizing its role as one of the gold standards for early-stage lung cancer diagnosis.

When a "puncture needle" is applied to the lungs, it carries a vastly different mission-extracting cells or tissue strips from the tissue to determine the benign or malignant nature of the lesion. Transthoracic Needle Biopsy (TTNB) is one of the most challenging procedures in modern thoracic surgery and interventional radiology, akin to a tightrope walk between "precision diagnosis" and "potential risks."

I. Why Must We "Puncture"? - An Unavoidable Diagnostic Dilemma

For solitary pulmonary nodules discovered through imaging examinations (such as CT), especially those located in the peripheral lungs where bronchoscopy is difficult to reach, TTNB is currently the most reliable means of obtaining a pathological diagnosis. Its diagnostic accuracy rate exceeds 90%, directly determining whether subsequent treatment involves surgical resection, radiotherapy, chemotherapy, or targeted therapy. Without a clear pathological result, all treatments are blind.

II. Selection of Puncture Needles and the Art of Operation

Unlike the fine needles used in dry needling therapy, hollow needles with cutting grooves or aspiration functions (such as cutting needles and coaxial needles) are commonly used for lung punctures. The procedure is usually guided by CT or ultrasound; the physician must meticulously plan the needle path, avoiding ribs, interlobar fissures, large blood vessels, and major bronchi. Throughout the process, the patient's respiratory cooperation is crucial, as every deep breath can displace the lesion by several centimeters.

III. Risk Management: The Trade-off Between Pneumothorax and Bleeding

The greatest risks of TTNB are pneumothorax (incidence rate approximately 15%-30%) and intrapulmonary hemorrhage (hemoptysis). This is because the lungs are gas-filled organs; any puncture can potentially cause alveolar rupture, allowing air to enter the pleural cavity. Furthermore, lung tissue is rich in blood supply, and needle tract injury can easily lead to bleeding.

To mitigate these risks, physicians have developed various strategies:

• Coaxial Needle Technique:​ First, a thicker cannula needle is used to establish a channel, through which multiple samples are taken, reducing repeated punctures' damage to the pleura.
• Path Selection:​ Prioritize paths that pass through a small amount of normal lung tissue, or directly puncture lesions adjacent to the chest wall.
• Postoperative Management:​ Immediately after needle withdrawal, instruct the patient to hold their breath and lie flat, observing for pneumothorax progression under CT. Small pneumothoraces can resolve spontaneously, while large ones require closed thoracic drainage.

IV. Future Directions: Safer and Smarter

With the maturation of robot-assisted puncture systems and electromagnetic navigation technology, future lung punctures will become more precise, automated, and safe. For instance, robots can stably compensate for errors caused by patient respiratory movements, locking the needle tip onto millimeter-level target points. Concurrently, the application of new hemostatic materials and biological glues may also significantly reduce bleeding risks.

In summary, lung biopsy is an indispensable link in the lung cancer diagnosis and treatment chain. It trades a "precise risk" for clear treatment direction and survival opportunities for countless patients.